Literature DB >> 3654148

Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells.

S D Henderson1, B F Kimler, M L Barnes.   

Abstract

The cytotoxic activity of various chemotherapy agents was investigated in asynchronous populations of cultured 9L rat brain tumor cells, and as a function of their position in the cell cycle. Representative drugs from the classes of DNA-active agents, alkylating agents, spindle poisons, and antimetabolites were tested. The ability to induce cell lethality in asynchronous populations as a function of drug concentration varied for 1 hr pulse exposures. In order of decreasing cytotoxic activity, DHAQ was the most effective, followed by VCR, VDS, VBL, ADR, BCNU, cis-DDP, BLM, DBD, RZ, and HU. The effect of chemotherapy agents on synchronous 9L cells obtained by mitotic selection also varied with respect to the individual agent and was cell cycle-dependent. Survival age-responses ranged from being minimal to demonstrating significant fluctuations as a function of cell cycle position. For all agents except ADR and HU, the sensitivity of G1 phase was greater than S phase. RZ exhibited essentially a flat age-response. Comparison of the cell cycle age-responses of chemotherapeutic agents to those exhibited by the cytotoxic modalities of radiation and hyperthermia demonstrate several unique differences.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654148     DOI: 10.1007/BF00203539

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  27 in total

1.  Action of hydroxyurea on the nucleic acid metabolism and viability of HeLa cells.

Authors:  J H Kim; A S Gelbard; A G Perez
Journal:  Cancer Res       Date:  1967-07       Impact factor: 12.701

2.  Studies on bleomycin.

Authors:  H Umezawa; M Ishizuka; K Maeda; T Takeuchi
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

3.  Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells.

Authors:  H Madoc-Jones; F Mauro
Journal:  J Cell Physiol       Date:  1968-12       Impact factor: 6.384

4.  Effects of cytostatics on proliferating and stationary cultures of mammalian cells.

Authors:  E Olah; I Palyi; J Sugar
Journal:  Eur J Cancer       Date:  1978-08       Impact factor: 9.162

Review 5.  Cell cycle effects of alkylating agents.

Authors:  R E Meyn; D Murray
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

6.  Interaction of hyperthermia and radiation on the survival of synchronous 9L cells.

Authors:  S D Henderson; B F Kimler; M F Scanlan
Journal:  Radiat Res       Date:  1982-10       Impact factor: 2.841

7.  Perturbed cell kinetics of 9L rat brain tumor cells following dianhydrogalactitol.

Authors:  K Nomura; T Hoshino; D F Deen; K D Knebel
Journal:  Cancer Treat Rep       Date:  1978-12

8.  Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle.

Authors:  W K Sinclair
Journal:  Science       Date:  1965-12-24       Impact factor: 47.728

9.  Interaction of razoxane and radiation on cultured Chinese hamster cells.

Authors:  B F Kimler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-08       Impact factor: 7.038

Review 10.  Bleomycin--mode of action with particular reference to the cell cycle.

Authors:  P R Twentyman
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

View more
  3 in total

1.  Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.

Authors:  P B Jensen; H Roed; L Vindeløv; I J Christensen; H H Hansen
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

2.  Intracerebral chemotherapy in the 9L rat brain tumor model.

Authors:  B F Kimler; C Liu; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

3.  The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.

Authors:  B F Kimler
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.